shRNA targeting PLK1 inhibits the proliferation and invasion of nasopharyngeal carcinoma cells

BACKGROUND: Polo-like kinase 1 (PLK1) is a serine/threonine protein kinase, which has been studied as a potential gene therapy target for many years. PLK1 is overexpressed in a variety of tumors, and its expression often negatively correlated with patient prognosis. However, the role of PLK1 in naso...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yan, Wu, Chu, Liu, Bingxue, Zhu, Juan, Zhong, Yating, Yuan, Yuqing, Huang, Yue, Tang, Yunlian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798612/
https://www.ncbi.nlm.nih.gov/pubmed/35117900
http://dx.doi.org/10.21037/tcr-20-811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798612/
https://www.ncbi.nlm.nih.gov/pubmed/35117900
http://dx.doi.org/10.21037/tcr-20-811

Ejemplares similares